NCT06967857View on ClinicalTrials.gov

Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Attention-Deficit/Hyperactivity Disorder (ADHD)Depression - Major Depressive Disorder
Interventions
DRUG

DEX IR tablets

tablet twice daily

DRUG

DEX XL

capsule once daily

DRUG

Placebo

Placebo to either capsule or tablet

Trial Locations (2)

60590

Department of Psychiatry, Psychosomatics and Psychotherapy University Hospital Frankfurt am Main - Goethe University, Frankfurt

04103

University Leipzig, Department of Psychiatry and Psychotherapy, Leipzig

All Listed Sponsors
lead

Prof. Dr. Frank Behrens

OTHER

NCT06967857 - Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression | Biotech Hunter | Biotech Hunter